GlaxoSmithKline Recalls 394,000 Bottles of DynaCirc

GlaxoSmithKline has issued a recall for more than 394,000 bottles of a high-blood pressure drug because of possible tablet mix-ups at a Novartis AG plant that supplies the drug.

According to the Wall Street Journal, the Food and Drug Administration inspected the Novartis plant in Lincoln, Nebraska and found that tablets of certain medicines were being put inside the wrong bottles.

There have been no adverse events reported in relation to the drug recall.

The Novartis Lincoln plant has also caused a recall of other drugs such as headache reliever Excedrin and has disrupted the supplies for certain pain drugs from Endo Pharmaceuticals Inc.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law for a free legal consultation and to find out if a dangerous drug lawyermay be able to help you and represent your case.

Tags: